Cancer-associated carbonic anhydrases and their inhibition.
about
The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivoCrystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IXInhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulphonamidesThe structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitorsInfrequent loss of luminal differentiation in ductal breast cancer metastasisAssociation of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortiumGdmCl-induced unfolding studies of human carbonic anhydrase IX: a combined spectroscopic and MD simulation approach.Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study.Identification of a novel small molecule HIF-1alpha translation inhibitor.Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.Recent progress in histochemistry and cell biology.Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor modelEstimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodesIn vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.Beta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxiaCarnosine inhibits carbonic anhydrase IX-mediated extracellular acidosis and suppresses growth of HeLa tumor xenografts.ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH.Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.Common Variants for Heart Failure.Celecoxib pathways: pharmacokinetics and pharmacodynamics.Imaging virus-associated cancer.Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer.Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies.Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis.Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Hypoxia induces cancer-associated cAMP/PKA signalling through HIF-mediated transcriptional control of adenylyl cyclases VI and VII.Selective inhibition of human carbonic anhydrase IX in Xenopus oocytes and MDA-MB-231 breast cancer cells.Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly.Synthesis of Novel 1-(4-Substituted pyridine-3-sulfonyl)-3-phenylureas with Potential Anticancer Activity.Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro.Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition.Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells.
P2860
Q26827175-2C7588D8-62CF-4797-9165-3103554C6DAFQ27657692-924BC9DC-EAC5-42F0-A71E-401D3B7FB0CEQ27659917-6FEEA600-BD70-4FBF-9A0C-14A5D64C1FC3Q27688043-1D5BFB49-C844-4264-AAF0-4E652B8935E7Q28534555-83EAA11B-FE69-4248-8054-3BF53C329D8EQ28943463-C4EE1E1B-246C-457D-BAFF-8A38D6330A7DQ30387067-A14F058B-625F-45A2-9B51-0FF6A6C0A667Q30433038-A8EA53D8-C848-466B-8BF9-0D99044DBAB4Q33507488-9316F78C-B4E6-45AA-B895-BBC85CAE8EC8Q34017131-1C0A4F9F-1799-44EB-8124-26B33A1D51D1Q34172616-8B8126C0-646D-4E53-9B25-BF5115D661FBQ34205104-69CA291F-BBFD-4011-AA40-3D603A7DBC36Q34294766-3940B59C-8C5D-43FE-9CF5-62009CA3A751Q34506028-174A92A6-F20D-4151-8D25-0E242409156FQ35049230-F12B54EB-DA2C-41F8-BD0A-490F20DD9777Q35179602-E5757025-038E-4DC0-BDBD-960B5907F92CQ35497226-CA12DCEA-72D8-4372-9A87-E073888FB099Q35740073-29E1D200-C9CB-418B-873F-CB85435E6DE2Q35742147-EAF36846-7D93-4445-A769-C9DDED800093Q35830941-EA101327-1E0D-4049-8BE5-0EE7293CDA80Q36015054-B24FE146-DCEE-47D0-AD05-BDD1D705B5E7Q36201349-891096ED-A1D9-45CE-9C10-10E005B6FB2BQ36581797-7EA84F21-EFE7-4EFB-A76F-251E8422FD72Q36738790-95F3A105-44D8-4FD6-9B2C-A69856C10EDEQ37295258-D7D55D0F-06EB-44AF-BBB0-5A03CDE279A0Q37320501-4CE5767A-0CCE-4288-A94F-34D286C60118Q37426436-815DE905-B707-4C49-B097-B72D25C7424DQ37728362-EEC4D32A-7A62-4BEE-9D28-6170FF5A61FDQ37729488-C70EE983-83E5-437D-971D-D314A5C15051Q38106734-5CEC1D2D-AB09-439B-BF5F-386F2AC3AE43Q38401664-FF0A797C-5812-431C-91DF-729D52E98020Q38599072-697E7FCC-278A-42CB-A0D7-BCC8078F1D07Q38750372-DA8FD816-7E0A-4F05-A165-53191C0D00D4Q38769524-E8DEDBE9-3988-45B2-AA2B-F92BD5B6C576Q38827659-0EA7914B-F223-45B9-836C-B2A49F2F7550Q38856989-CB20EEC0-376A-4A33-BB7C-FE0B1E919E18Q38968651-7C943B82-F735-40B5-9841-8E7C06E87B9FQ39393517-070E852D-2532-4693-AA66-20BB02BB7D9CQ39596916-D147FBC3-A7BC-4955-81C3-63625FCE9119Q39637431-0E159802-2CC2-41D0-A907-75556C53B206
P2860
Cancer-associated carbonic anhydrases and their inhibition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cancer-associated carbonic anhydrases and their inhibition.
@en
Cancer-associated carbonic anhydrases and their inhibition.
@nl
type
label
Cancer-associated carbonic anhydrases and their inhibition.
@en
Cancer-associated carbonic anhydrases and their inhibition.
@nl
prefLabel
Cancer-associated carbonic anhydrases and their inhibition.
@en
Cancer-associated carbonic anhydrases and their inhibition.
@nl
P2093
P1476
Cancer-associated carbonic anhydrases and their inhibition.
@en
P2093
J Pastorek
M Zatovicova
S Pastorekova
P304
P356
10.2174/138161208783877893
P577
2008-01-01T00:00:00Z